Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

Scleroderma: Cyclophosphamide or Transplantation (SCOT) Substudy 03
Mechanistic Study: Molecular Analysis of T Cell Immune Recovery for the SCOT Trial
Status: Enrolling
Updated:  3/27/2009
mi
from
Los Angeles, CA
Scleroderma: Cyclophosphamide or Transplantation (SCOT) Substudy 03
Mechanistic Study: Molecular Analysis of T Cell Immune Recovery for the SCOT Trial
Status: Enrolling
Updated: 3/27/2009
UCLA Medical School
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Scleroderma: Cyclophosphamide or Transplantation (SCOT) Substudy 03
Mechanistic Study: Molecular Analysis of T Cell Immune Recovery for the SCOT Trial
Status: Enrolling
Updated:  3/27/2009
mi
from
Boston, MA
Scleroderma: Cyclophosphamide or Transplantation (SCOT) Substudy 03
Mechanistic Study: Molecular Analysis of T Cell Immune Recovery for the SCOT Trial
Status: Enrolling
Updated: 3/27/2009
Boston University School of Medicine
mi
from
Boston, MA
Click here to add this to my saved trials
Scleroderma: Cyclophosphamide or Transplantation (SCOT) Substudy 03
Mechanistic Study: Molecular Analysis of T Cell Immune Recovery for the SCOT Trial
Status: Enrolling
Updated:  3/27/2009
mi
from
Ann Arbor, MI
Scleroderma: Cyclophosphamide or Transplantation (SCOT) Substudy 03
Mechanistic Study: Molecular Analysis of T Cell Immune Recovery for the SCOT Trial
Status: Enrolling
Updated: 3/27/2009
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Scleroderma: Cyclophosphamide or Transplantation (SCOT) Substudy 03
Mechanistic Study: Molecular Analysis of T Cell Immune Recovery for the SCOT Trial
Status: Enrolling
Updated:  3/27/2009
mi
from
Durham, NC
Scleroderma: Cyclophosphamide or Transplantation (SCOT) Substudy 03
Mechanistic Study: Molecular Analysis of T Cell Immune Recovery for the SCOT Trial
Status: Enrolling
Updated: 3/27/2009
Duke University
mi
from
Durham, NC
Click here to add this to my saved trials
Scleroderma: Cyclophosphamide or Transplantation (SCOT) Substudy 03
Mechanistic Study: Molecular Analysis of T Cell Immune Recovery for the SCOT Trial
Status: Enrolling
Updated:  3/27/2009
mi
from
Houston, TX
Scleroderma: Cyclophosphamide or Transplantation (SCOT) Substudy 03
Mechanistic Study: Molecular Analysis of T Cell Immune Recovery for the SCOT Trial
Status: Enrolling
Updated: 3/27/2009
University of Texas- Houston Medical School
mi
from
Houston, TX
Click here to add this to my saved trials
Scleroderma: Cyclophosphamide or Transplantation (SCOT) Substudy 03
Mechanistic Study: Molecular Analysis of T Cell Immune Recovery for the SCOT Trial
Status: Enrolling
Updated:  3/27/2009
mi
from
Seattle, WA
Scleroderma: Cyclophosphamide or Transplantation (SCOT) Substudy 03
Mechanistic Study: Molecular Analysis of T Cell Immune Recovery for the SCOT Trial
Status: Enrolling
Updated: 3/27/2009
Fred Hutchinson Cancer Research Center (FHCRC)
mi
from
Seattle, WA
Click here to add this to my saved trials
Scleroderma: Cyclophosphamide or Transplantation (SCOT) Substudy 03
Mechanistic Study: Molecular Analysis of T Cell Immune Recovery for the SCOT Trial
Status: Enrolling
Updated:  3/27/2009
mi
from
Milwaukee, WI
Scleroderma: Cyclophosphamide or Transplantation (SCOT) Substudy 03
Mechanistic Study: Molecular Analysis of T Cell Immune Recovery for the SCOT Trial
Status: Enrolling
Updated: 3/27/2009
Medical College of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Organizational Skills Training for Children With Attention Deficit Hyperactivity Disorder
Organizational Skills Treatment for ADHD Children
Status: Enrolling
Updated:  4/8/2009
mi
from
New York, NY
Organizational Skills Training for Children With Attention Deficit Hyperactivity Disorder
Organizational Skills Treatment for ADHD Children
Status: Enrolling
Updated: 4/8/2009
New York University Child Study Center
mi
from
New York, NY
Click here to add this to my saved trials
Organizational Skills Training for Children With Attention Deficit Hyperactivity Disorder
Organizational Skills Treatment for ADHD Children
Status: Enrolling
Updated:  4/8/2009
mi
from
Durham, NC
Organizational Skills Training for Children With Attention Deficit Hyperactivity Disorder
Organizational Skills Treatment for ADHD Children
Status: Enrolling
Updated: 4/8/2009
Duke University
mi
from
Durham, NC
Click here to add this to my saved trials
Long-Term Olanzapine Treatment in Children With Autism
Long-Term Olanzapine Treatment in Children With Autism
Status: Enrolling
Updated:  4/29/2009
mi
from
Philadelphia, PA
Long-Term Olanzapine Treatment in Children With Autism
Long-Term Olanzapine Treatment in Children With Autism
Status: Enrolling
Updated: 4/29/2009
Drexel University College of Medicine at Friends Hospital
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Cryptogenic Stroke Study
Long-Term Cardiac Monitoring for Detection of Atrial Fibrillation After Cryptogenic Stroke
Status: Enrolling
Updated:  5/4/2009
mi
from
Columbus, OH
Cryptogenic Stroke Study
Long-Term Cardiac Monitoring for Detection of Atrial Fibrillation After Cryptogenic Stroke
Status: Enrolling
Updated: 5/4/2009
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
The Effects of Exercise Versus Inactivity on People With Mitochondrial Muscle Disease
Exercise Training and Deconditions: Implications for Therapy in Mitochondrial Myopathy
Status: Enrolling
Updated:  5/18/2009
mi
from
Dallas, TX
The Effects of Exercise Versus Inactivity on People With Mitochondrial Muscle Disease
Exercise Training and Deconditions: Implications for Therapy in Mitochondrial Myopathy
Status: Enrolling
Updated: 5/18/2009
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Cortex Changes in Real/Imagined Movements in Amyotrophic Lateral Sclerosis (ALS)
Tracking Brain Changes During Real and Imagined Movements in People With ALS (Lou Gehrig's Disease) and Healthy Volunteers.
Status: Enrolling
Updated:  5/26/2009
mi
from
Ann Arbor, MI
Cortex Changes in Real/Imagined Movements in Amyotrophic Lateral Sclerosis (ALS)
Tracking Brain Changes During Real and Imagined Movements in People With ALS (Lou Gehrig's Disease) and Healthy Volunteers.
Status: Enrolling
Updated: 5/26/2009
University of Michigan, Functional MRI Laboratory
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Effects of Strattera and Behavior Therapy on the School and Home Functioning of Elementary School Children With Attention-Deficit/Hyperactivity Disorder (ADHD)
Effects of Strattera and Behavior Therapy on the School and Home Functioning of Elementary School Children With Attention-Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  6/10/2009
mi
from
Buffalo, NY
Effects of Strattera and Behavior Therapy on the School and Home Functioning of Elementary School Children With Attention-Deficit/Hyperactivity Disorder (ADHD)
Effects of Strattera and Behavior Therapy on the School and Home Functioning of Elementary School Children With Attention-Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 6/10/2009
Cennter for Children and Families
mi
from
Buffalo, NY
Click here to add this to my saved trials
Treatment Routes for Exploring Agitation
Treatment of Agitation in the Nursing Home
Status: Enrolling
Updated:  7/1/2009
mi
from
Rockville, MD
Treatment Routes for Exploring Agitation
Treatment of Agitation in the Nursing Home
Status: Enrolling
Updated: 7/1/2009
Research Institute on Aging
mi
from
Rockville, MD
Click here to add this to my saved trials
Study of Fluconazole in Children With Autism Spectrum Disorder
A Double-Blind, Placebo-Controlled Study of the Efficacy of Fluconazole as a Treatment for Autism Spectrum Disorder
Status: Enrolling
Updated:  7/8/2009
mi
from
Tarzana, CA
Study of Fluconazole in Children With Autism Spectrum Disorder
A Double-Blind, Placebo-Controlled Study of the Efficacy of Fluconazole as a Treatment for Autism Spectrum Disorder
Status: Enrolling
Updated: 7/8/2009
Center for Autism and Related Disorders
mi
from
Tarzana, CA
Click here to add this to my saved trials
Study of Fluconazole in Children With Autism Spectrum Disorder
A Double-Blind, Placebo-Controlled Study of the Efficacy of Fluconazole as a Treatment for Autism Spectrum Disorder
Status: Enrolling
Updated:  7/8/2009
mi
from
Melbourne, FL
Study of Fluconazole in Children With Autism Spectrum Disorder
A Double-Blind, Placebo-Controlled Study of the Efficacy of Fluconazole as a Treatment for Autism Spectrum Disorder
Status: Enrolling
Updated: 7/8/2009
International Child Development Resource Center
mi
from
Melbourne, FL
Click here to add this to my saved trials
Study of Fluconazole in Children With Autism Spectrum Disorder
A Double-Blind, Placebo-Controlled Study of the Efficacy of Fluconazole as a Treatment for Autism Spectrum Disorder
Status: Enrolling
Updated:  7/8/2009
mi
from
Austin, TX
Study of Fluconazole in Children With Autism Spectrum Disorder
A Double-Blind, Placebo-Controlled Study of the Efficacy of Fluconazole as a Treatment for Autism Spectrum Disorder
Status: Enrolling
Updated: 7/8/2009
Thoughtful House
mi
from
Austin, TX
Click here to add this to my saved trials
Phase II High-Dose Cyclophosphamide for Multiple Sclerosis
Phase II Trial of High-dose Cyclophosphamide for Moderate to Severe Refractory Multiple Sclerosis
Status: Enrolling
Updated:  7/21/2009
mi
from
Stony Brook, NY
Phase II High-Dose Cyclophosphamide for Multiple Sclerosis
Phase II Trial of High-dose Cyclophosphamide for Moderate to Severe Refractory Multiple Sclerosis
Status: Enrolling
Updated: 7/21/2009
Stony Brook University Hospital
mi
from
Stony Brook, NY
Click here to add this to my saved trials
A Pilot Study of Ultra Rapid Opioid Rotation and Titration of Oxymorphone
A Pilot Study of Ultra Rapid Opioid Rotation and Titration of Oxymorphone
Status: Enrolling
Updated:  7/23/2009
mi
from
New York, NY
A Pilot Study of Ultra Rapid Opioid Rotation and Titration of Oxymorphone
A Pilot Study of Ultra Rapid Opioid Rotation and Titration of Oxymorphone
Status: Enrolling
Updated: 7/23/2009
Mount Sinai School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Study of Generalized Movements for Early Prediction of Cerebral Palsy
Early Prediction of Cerebral Palsy in Preterm Infants and Term Infants Using Detection of Generalized Movements
Status: Enrolling
Updated:  8/3/2009
mi
from
Honolulu, HI
Study of Generalized Movements for Early Prediction of Cerebral Palsy
Early Prediction of Cerebral Palsy in Preterm Infants and Term Infants Using Detection of Generalized Movements
Status: Enrolling
Updated: 8/3/2009
Kapiolani Medical Center for Women and Children
mi
from
Honolulu, HI
Click here to add this to my saved trials
Neurophysiology and Anatomy of Severe Intraventricular Hemorrhage (IVH)
Influence of Altered Cerebral Spinal Fluid and Arterial Flows on Cerebral Processing Functions in Premature Infants With Severe Intraventricular Hemorrhage
Status: Enrolling
Updated:  8/11/2009
mi
from
Nashville, TN
Neurophysiology and Anatomy of Severe Intraventricular Hemorrhage (IVH)
Influence of Altered Cerebral Spinal Fluid and Arterial Flows on Cerebral Processing Functions in Premature Infants With Severe Intraventricular Hemorrhage
Status: Enrolling
Updated: 8/11/2009
Monroe Carell Children's Hospital at Vanderbilt, NICU
mi
from
Nashville, TN
Click here to add this to my saved trials
Body Composition Assessment in Spinal Cord Injury
Body Composition Assessment in Spinal Cord Injury
Status: Enrolling
Updated:  8/11/2009
mi
from
Richmond, VA
Body Composition Assessment in Spinal Cord Injury
Body Composition Assessment in Spinal Cord Injury
Status: Enrolling
Updated: 8/11/2009
Hunter Holmes McGuire Spinal Cord Injury Research Lab
mi
from
Richmond, VA
Click here to add this to my saved trials
Safety of Polyphenon E in Multiple Sclerosis Pilot Study
Safety and Neuroprotective Effects of Polyphenon E in Multiple Sclerosis
Status: Enrolling
Updated:  8/13/2009
mi
from
New Orleans, LA
Safety of Polyphenon E in Multiple Sclerosis Pilot Study
Safety and Neuroprotective Effects of Polyphenon E in Multiple Sclerosis
Status: Enrolling
Updated: 8/13/2009
Louisiana Health Sciences Center New Orleans
mi
from
New Orleans, LA
Click here to add this to my saved trials
Cost-Effectiveness of a Specialized Ultrasound Instrument to Diagnose Carotid Stenosis as a Way to Reduce the Risk of Stroke
New Ultrasound Instrument for Carotid Screening
Status: Enrolling
Updated:  8/25/2009
mi
from
Princeton, NJ
Cost-Effectiveness of a Specialized Ultrasound Instrument to Diagnose Carotid Stenosis as a Way to Reduce the Risk of Stroke
New Ultrasound Instrument for Carotid Screening
Status: Enrolling
Updated: 8/25/2009
Princeton Surgical Associates
mi
from
Princeton, NJ
Click here to add this to my saved trials
Effectiveness of ATMX in Treating Adolescents With ADHD and SUD
Atomoxetine in Adolescents With Attention Deficit Hyperactivity Disorder (ADHD) and Substance Use Disorder (SUD)
Status: Enrolling
Updated:  9/2/2009
mi
from
Boston, MA
Effectiveness of ATMX in Treating Adolescents With ADHD and SUD
Atomoxetine in Adolescents With Attention Deficit Hyperactivity Disorder (ADHD) and Substance Use Disorder (SUD)
Status: Enrolling
Updated: 9/2/2009
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Enhancing ADHD Driving Performance With Stimulant Medication
Enhancing ADHD Driving Performance With Stimulant Medication
Status: Enrolling
Updated:  9/2/2009
mi
from
Charlottesville, VA
Enhancing ADHD Driving Performance With Stimulant Medication
Enhancing ADHD Driving Performance With Stimulant Medication
Status: Enrolling
Updated: 9/2/2009
University of Virginia
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Effect of Intravenous Acetadote on Incidence of Contrast Induced Nephropathy
N-Acetylcysteine to Prevent Contrast-Induced Nephropathy in Acute Coronary Syndromes
Status: Enrolling
Updated:  9/17/2009
mi
from
New Orleans, LA
Effect of Intravenous Acetadote on Incidence of Contrast Induced Nephropathy
N-Acetylcysteine to Prevent Contrast-Induced Nephropathy in Acute Coronary Syndromes
Status: Enrolling
Updated: 9/17/2009
Ochsner Medical Center
mi
from
New Orleans, LA
Click here to add this to my saved trials
Safety and Efficacy Study of Clevidipine to Control Hypertension in Patients Admitted With Aneurysmal Subarachnoid Hemorrhage
Clevidipine in Aneurysmal Subarachnoid Hemorrhage, A Pilot Study
Status: Enrolling
Updated:  9/17/2009
mi
from
Detroit, MI
Safety and Efficacy Study of Clevidipine to Control Hypertension in Patients Admitted With Aneurysmal Subarachnoid Hemorrhage
Clevidipine in Aneurysmal Subarachnoid Hemorrhage, A Pilot Study
Status: Enrolling
Updated: 9/17/2009
Henry Ford Hospital
mi
from
Detroit, MI
Click here to add this to my saved trials
Bioavailability of Ubiquinol in Huntington Disease
Bioavailability of Ubiquinol in Huntington Disease
Status: Enrolling
Updated:  9/18/2009
mi
from
Rochester, NY
Bioavailability of Ubiquinol in Huntington Disease
Bioavailability of Ubiquinol in Huntington Disease
Status: Enrolling
Updated: 9/18/2009
University of Rochester
mi
from
Rochester, NY
Click here to add this to my saved trials
Fatigue, Sleep Disorders and Endocrine Abnormalities in TBI Patients
The Relationship Between Fatigue, Sleep Disorders and Endocrine Abnormalities Following Traumatic Brain Injury
Status: Enrolling
Updated:  10/2/2009
mi
from
West Orange, NJ
Fatigue, Sleep Disorders and Endocrine Abnormalities in TBI Patients
The Relationship Between Fatigue, Sleep Disorders and Endocrine Abnormalities Following Traumatic Brain Injury
Status: Enrolling
Updated: 10/2/2009
Kessler Foundation Research Center
mi
from
West Orange, NJ
Click here to add this to my saved trials
Telepharmacy Robotic Medicine Delivery Unit "TRMDU" Assessment
Evaluation of a Telepharmacy Robotic Medicine Delivery Unit in Warrior Transition Unit Patients With Traumatic Brain Injury, Post-Traumatic Stress Disorder, or Polytrauma
Status: Enrolling
Updated:  11/3/2009
mi
from
Camp Pendleton, CA
Telepharmacy Robotic Medicine Delivery Unit "TRMDU" Assessment
Evaluation of a Telepharmacy Robotic Medicine Delivery Unit in Warrior Transition Unit Patients With Traumatic Brain Injury, Post-Traumatic Stress Disorder, or Polytrauma
Status: Enrolling
Updated: 11/3/2009
Naval Hospital Camp Pendleton
mi
from
Camp Pendleton, CA
Click here to add this to my saved trials
Telepharmacy Robotic Medicine Delivery Unit "TRMDU" Assessment
Evaluation of a Telepharmacy Robotic Medicine Delivery Unit in Warrior Transition Unit Patients With Traumatic Brain Injury, Post-Traumatic Stress Disorder, or Polytrauma
Status: Enrolling
Updated:  11/3/2009
mi
from
Tampa, FL
Telepharmacy Robotic Medicine Delivery Unit "TRMDU" Assessment
Evaluation of a Telepharmacy Robotic Medicine Delivery Unit in Warrior Transition Unit Patients With Traumatic Brain Injury, Post-Traumatic Stress Disorder, or Polytrauma
Status: Enrolling
Updated: 11/3/2009
James A Haley VA Hospital and Polytrauma Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
Telepharmacy Robotic Medicine Delivery Unit "TRMDU" Assessment
Evaluation of a Telepharmacy Robotic Medicine Delivery Unit in Warrior Transition Unit Patients With Traumatic Brain Injury, Post-Traumatic Stress Disorder, or Polytrauma
Status: Enrolling
Updated:  11/3/2009
mi
from
Fort Knox, KY
Telepharmacy Robotic Medicine Delivery Unit "TRMDU" Assessment
Evaluation of a Telepharmacy Robotic Medicine Delivery Unit in Warrior Transition Unit Patients With Traumatic Brain Injury, Post-Traumatic Stress Disorder, or Polytrauma
Status: Enrolling
Updated: 11/3/2009
Ireland Army Community Hospital
mi
from
Fort Knox, KY
Click here to add this to my saved trials
Huperzine-A to Help With Mental Problems and the Inability to Care for Onself in Patients With Schizophrenia
Huperzine-A for Cognitive Dysfunction and Functional Status in Schizophrenia
Status: Enrolling
Updated:  11/12/2009
mi
from
Omaha, NE
Huperzine-A to Help With Mental Problems and the Inability to Care for Onself in Patients With Schizophrenia
Huperzine-A for Cognitive Dysfunction and Functional Status in Schizophrenia
Status: Enrolling
Updated: 11/12/2009
Veterans Affairs Nebraska Western Iowa Health Care System
mi
from
Omaha, NE
Click here to add this to my saved trials
Delayed Versus Early Enoxaparin Prophylaxis After Traumatic Brain Injury (TBI)
The Delayed vs Early Enoxaparin Prophylaxis (DEEP) Study After Traumatic Brain Injury: A Randomized, Double-Blinded, Placebo Controlled Pilot Trial
Status: Enrolling
Updated:  11/16/2009
mi
from
Dallas, TX
Delayed Versus Early Enoxaparin Prophylaxis After Traumatic Brain Injury (TBI)
The Delayed vs Early Enoxaparin Prophylaxis (DEEP) Study After Traumatic Brain Injury: A Randomized, Double-Blinded, Placebo Controlled Pilot Trial
Status: Enrolling
Updated: 11/16/2009
U.T. Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Delayed Versus Early Enoxaparin Prophylaxis After Traumatic Brain Injury (TBI)
The Delayed vs Early Enoxaparin Prophylaxis (DEEP) Study After Traumatic Brain Injury: A Randomized, Double-Blinded, Placebo Controlled Pilot Trial
Status: Enrolling
Updated:  11/16/2009
mi
from
Tyler, TX
Delayed Versus Early Enoxaparin Prophylaxis After Traumatic Brain Injury (TBI)
The Delayed vs Early Enoxaparin Prophylaxis (DEEP) Study After Traumatic Brain Injury: A Randomized, Double-Blinded, Placebo Controlled Pilot Trial
Status: Enrolling
Updated: 11/16/2009
East Texas Medical Center
mi
from
Tyler, TX
Click here to add this to my saved trials
Double Blind, Crossover Study of Fish Oil [EPA and DHA] for Intractable Partial Seizures
Pilot Randomized Double Blind Crossover Study Of Fish Oil [Eicosapentaenoic Acid (EPA) And Docosahexaenoic Acid (DHA)] For Intractable Partial Seizures
Status: Enrolling
Updated:  12/4/2009
mi
from
Los Angeles, CA
Double Blind, Crossover Study of Fish Oil [EPA and DHA] for Intractable Partial Seizures
Pilot Randomized Double Blind Crossover Study Of Fish Oil [Eicosapentaenoic Acid (EPA) And Docosahexaenoic Acid (DHA)] For Intractable Partial Seizures
Status: Enrolling
Updated: 12/4/2009
UCLA General Clinical Research Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Predictors of Cognitive Decline in Normal Aging
Predictors of Cognitive Decline in Normal Aging
Status: Enrolling
Updated:  12/10/2009
mi
from
New York City, NY
Predictors of Cognitive Decline in Normal Aging
Predictors of Cognitive Decline in Normal Aging
Status: Enrolling
Updated: 12/10/2009
Center for Brain Health, Silberstein Institute, New York University School of Medicine
mi
from
New York City, NY
Click here to add this to my saved trials
Exercise and Activities for Independent Living With Mild Cognitive Impairment (MCI)
Exercise & Health Promotion for MCI: A Controlled Trial
Status: Enrolling
Updated:  12/10/2009
mi
from
Seattle, WA
Exercise and Activities for Independent Living With Mild Cognitive Impairment (MCI)
Exercise & Health Promotion for MCI: A Controlled Trial
Status: Enrolling
Updated: 12/10/2009
Northwest Research Group on Aging, Department of Psychosocial and Community Health, University of Washington School of Nursing
mi
from
Seattle, WA
Click here to add this to my saved trials
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated:  12/21/2009
mi
from
Phoenix, AZ
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated: 12/21/2009
Mayo Clinic Hospital, Arizona
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated:  12/21/2009
mi
from
Fort Smith, AR
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated: 12/21/2009
Sparks Regional Medical Center
mi
from
Fort Smith, AR
Click here to add this to my saved trials
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated:  12/21/2009
mi
from
Loma Linda, CA
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated: 12/21/2009
Loma Linda University School of Medicine
mi
from
Loma Linda, CA
Click here to add this to my saved trials
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated:  12/21/2009
mi
from
Los Angeles, CA
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated: 12/21/2009
Santa Monica - UCLA Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated:  12/21/2009
mi
from
Los Angeles, CA
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated: 12/21/2009
UCLA Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated:  12/21/2009
mi
from
Newport Beach, CA
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated: 12/21/2009
Hoag Memorial Hospital
mi
from
Newport Beach, CA
Click here to add this to my saved trials
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated:  12/21/2009
mi
from
Oceanside, CA
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated: 12/21/2009
The Neurology Center: Tri-City Medical Center
mi
from
Oceanside, CA
Click here to add this to my saved trials
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated:  12/21/2009
mi
from
Redding, CA
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated: 12/21/2009
Shasta Regional Medical
mi
from
Redding, CA
Click here to add this to my saved trials
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated:  12/21/2009
mi
from
Bridgeport, CT
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated: 12/21/2009
Bridgeport Hospital
mi
from
Bridgeport, CT
Click here to add this to my saved trials
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated:  12/21/2009
mi
from
Fort Lauderdale, FL
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
Status: Enrolling
Updated: 12/21/2009
Neurologic Consultants, PA
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials